Using a vaccine-style approach, where the treatment prompts the body to generate its own antibodies, has the potential to solve these problems. Several companies are developing active immunotherapies to target Alzheimer’s and Parkinson’s disease, as well as other neurological conditions. The post Stopping Neurodegeneration in Place with Vaccines appeared first on Inside Precision Medicine .